These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27254543)

  • 1. Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.
    Yang J; Nies MK; Fu Z; Damico R; Korley FK; Hassoun PM; Ivy DD; Austin ED; Everett AD
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1264-1272. PubMed ID: 27254543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.
    Damico R; Kolb TM; Valera L; Wang L; Housten T; Tedford RJ; Kass DA; Rafaels N; Gao L; Barnes KC; Benza RL; Rand JL; Hamid R; Loyd JE; Robbins IM; Hemnes AR; Chung WK; Austin ED; Drummond MB; Mathai SC; Hassoun PM
    Am J Respir Crit Care Med; 2015 Jan; 191(2):208-18. PubMed ID: 25489667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival.
    Yang J; Ambade AS; Nies M; Griffiths M; Damico R; Vaidya D; Brandal S; Pauciulo MW; Lutz KA; Coleman AW; Nichols WC; Austin ED; Ivy D; Hassoun PM; Everett AD
    Pulm Circ; 2022 Jan; 12(1):e12007. PubMed ID: 35506100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.
    Griffiths M; Yang J; Nies M; Vaidya D; Brandal S; Williams M; Matsui EC; Grant T; Damico R; Ivy D; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    Pediatr Res; 2020 Dec; 88(6):850-856. PubMed ID: 32927467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.
    Nickel NP; Lichtinghagen R; Golpon H; Olsson KM; Brand K; Welte T; Hoeper MM
    Respir Res; 2013 Nov; 14(1):130. PubMed ID: 24251953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
    Gao L; Skinner J; Nath T; Lin Q; Griffiths M; Damico RL; Pauciulo MW; Nichols WC; Hassoun PM; Everett AD; Johns RA
    Respir Res; 2024 Jun; 25(1):235. PubMed ID: 38844967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension.
    Calvier L; Legchenko E; Grimm L; Sallmon H; Hatch A; Plouffe BD; Schroeder C; Bauersachs J; Murthy SK; Hansmann G
    Heart; 2016 Mar; 102(5):390-6. PubMed ID: 26869635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency.
    Sweatt AJ; Miyagawa K; Rhodes CJ; Taylor S; Del Rosario PA; Hsi A; Haddad F; Spiekerkoetter E; Bental-Roof M; Bland RD; Swietlik EM; Gräf S; Wilkins MR; Morrell NW; Nicolls MR; Rabinovitch M; Zamanian RT
    Chest; 2021 Oct; 160(4):1442-1458. PubMed ID: 34181952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
    Han Y; Zhang W; Liu Y
    World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of homocysteine as a non-invasive and effort-free measurements for risk assessment of patients with pulmonary hypertension.
    Wang MT; Chi PL; Cheng CC; Huang WC; Chen LW
    Cardiol J; 2024; 31(2):285-299. PubMed ID: 37772357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
    Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
    BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension.
    Filusch A; Zelniker T; Baumgärtner C; Eschricht S; Frey N; Katus HA; Chorianopoulos E
    Clin Res Cardiol; 2011 Oct; 100(10):879-85. PubMed ID: 21479966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
    Takatsuki S; Wagner BD; Ivy DD
    Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension.
    Snipelisky D; Jentzer J; Batal O; Dardari Z; Mathier M
    Clin Cardiol; 2018 Jun; 41(6):782-787. PubMed ID: 29604093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
    Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
    J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.
    Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR
    Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.
    Al-Naamani N; Palevsky HI; Lederer DJ; Horn EM; Mathai SC; Roberts KE; Tracy RP; Hassoun PM; Girgis RE; Shimbo D; Post WS; Kawut SM;
    Ann Am Thorac Soc; 2016 Jan; 13(1):25-30. PubMed ID: 26501464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension.
    Wellbrock J; Harbaum L; Stamm H; Hennigs JK; Schulz B; Klose H; Bokemeyer C; Fiedler W; Lüneburg N
    Lung; 2015 Aug; 193(4):567-70. PubMed ID: 25926293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.
    Prins KW; Kalra R; Rose L; Assad TR; Archer SL; Bajaj NS; Weir EK; Prisco SZ; Pritzker M; Lutsey PL; Brittain EL; Thenappan T
    J Am Heart Assoc; 2020 Mar; 9(5):e015221. PubMed ID: 32079477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
    Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.